Seattle's latest headlines include a police investigation into a Scientology building break-in linked to the "speedrunning" trend and debates over the city's business climate with Howard Schultz criticizing Seattle's environment for entrepreneurs. A Washington court is also weighing whether insurers must cover GLP-1 drugs like Ozempic for obesity treatment, highlighting tensions over healthcare access and discrimination.